Apexian Pharmaceuticals' Series B Round

Apexian Pharmaceuticals raised a round of funding on July 11, 2018.

Apexian Therapeutics, formerly Apex Therapeutics, is a biotechnology company focused on developing novel compounds to treat cancer. The company's lead drug candidate – APX3330 – targets the APE1/R…

Articles about Apexian Pharmaceuticals' Series B Round: